Cost and resource utilization in cervical cancer management: a real-world retrospective cost analysis.
Curr Oncol
; 23(Suppl 1): S14-22, 2016 Feb.
Article
en En
| MEDLINE
| ID: mdl-26985142
ABSTRACT
OBJECTIVES:
We set out to assess the health care resource utilization and cost of cervical cancer from the perspective of a single-payer health care system.METHODS:
Retrospective observational data for women diagnosed with cervical cancer in British Columbia between 2004 and 2009 were analyzed to calculate patient-level resource utilization patterns from diagnosis to death or 5-year discharge. Domains of resource use within the scope of this cost analysis were chemotherapy, radiotherapy, and brachytherapy administered by the BC Cancer Agency; resource utilization related to hospitalization and outpatient visits as recorded by the B.C. Ministry of Health; medically required services billed under the B.C. Medical Services Plan; and prescriptions dispensed under British Columbia's health insurance programs. Unit costs were applied to radiotherapy and brachytherapy, producing per-patient costs.RESULTS:
The mean cost per case of treating cervical cancer in British Columbia was $19,153 (standard error $3,484). Inpatient hospitalizations, at 35%, represented the largest proportion of the total cost (95% confidence interval 32.9% to 36.9%). Costs were compared for subgroups of the total cohort.CONCLUSIONS:
As health care systems change the way they manage, screen for, and prevent cervical cancer, cost-effectiveness evaluations of the overall approach will require up-to-date data for resource utilization and costs. We provide information suitable for such a purpose and also identify factors that influence costs.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Tipo de estudio:
Health_economic_evaluation
/
Prognostic_studies
Idioma:
En
Revista:
Curr Oncol
Año:
2016
Tipo del documento:
Article